scholarly article | Q13442814 |
P50 | author | Thomas J. Hudson | Q3525236 |
John A. Todd | Q6217960 | ||
Dag Undlien | Q17113394 | ||
Jaakko Tuomilehto | Q28050079 | ||
David B. Dunger | Q40388857 | ||
Neil M Walker | Q44919496 | ||
Joanna Howson | Q55704445 | ||
Deborah Smyth | Q56436977 | ||
David P Strachan | Q64858751 | ||
Kjersti S Rønningen | Q87133702 | ||
Cristian Guja | Q87858483 | ||
Wendy L McArdle | Q87944939 | ||
Alex K Lam | Q88560952 | ||
Constantin Ionescu-Tirgoviste | Q93049170 | ||
Sarah Nutland | Q114721568 | ||
Rebecca C J Twells | Q117249563 | ||
Eva Tuomilehto-Wolf | Q117249577 | ||
Jayne Hutchings | Q117249582 | ||
P2093 | author name string | David Savage | |
Andrew D Paterson | |||
Xiao-Qing Liu | |||
Christopher E Lowe | |||
Bhupinder Bharaj | |||
Constantin Polychronakos | |||
Huiqi Qu | |||
Joseph A Curtis | |||
Leigh Anne Newhook | |||
Sukyung Park | |||
Yongsoo Park | |||
Dukhee Kim | |||
Seiwon Yang | |||
Jungu Kang | |||
P2860 | cites work | A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus | Q28259884 |
A 212-kb region on chromosome 6q25 containing the TAB2 gene is associated with susceptibility to type 1 diabetes | Q28268724 | ||
A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes | Q28271534 | ||
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies | Q29616285 | ||
Genome-wide association studies: theoretical and practical concerns | Q34555195 | ||
Betting odds and genetic associations. | Q52001328 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type-1 diabetes | Q124407 |
P304 | page(s) | 112; author reply 112-3 | |
111-2; author reply 112-3 | |||
110-1; author reply 112-3 | |||
P577 | publication date | 2005-02-01 | |
P1433 | published in | Nature Genetics | Q976454 |
P1476 | title | Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes | |
P478 | volume | 37 |
Q33587978 | Analyses of multiple single-nucleotide polymorphisms in the SUMO4/IDDM5 region in affected sib-pair families with type I diabetes |
Q33606764 | Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families. |
Q59697422 | Association of NFKB1 −94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease |
Q28275909 | Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients |
Q36666047 | Association of SUMO4, as a candidate gene for IDDM5, with susceptibility to type 1 diabetes in Asian populations |
Q37005340 | ERBB3-rs2292239 as primary type 1 diabetes association locus among non-HLA genes in Chinese |
Q37088194 | From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era. |
Q36816687 | Genes mediating environment interactions in type 1 diabetes |
Q36915466 | Genetic Basis of Type 1 Diabetes: Similarities and Differences between East and West |
Q28275898 | Genetic and functional evidence supporting SUMO4 as a type 1 diabetes susceptibility gene |
Q43695619 | Genetic epidemiology of type 1 diabetes |
Q39570426 | Genetic polymorphisms of NFκB1 -94 del/ins ATTG, NFκB1A 2758 A>G and SUMO rs237025 G>A in psoriasis |
Q36666056 | Genetics of type 1 diabetes: similarities and differences between Asian and Caucasian populations |
Q42976544 | Is a new immune response mediator in the NF-kappaB pathway--SUMO-4--related to type 1 diabetes? |
Q55044269 | Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. |
Q33942274 | Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms |
Q38206114 | Molecular mechanisms in autoimmune type 1 diabetes: a critical review. |
Q51123079 | Network medicine analysis of chondrocyte proteins towards new treatments of osteoarthritis. |
Q28293968 | No association of SUMO4 M55V with autoimmune diabetes in Asian-Indian patients |
Q56901681 | No evidence of association of CTLA-4 -318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetes |
Q84906310 | Polymorphism M55V in gene encoding small ubiquitin-like modifier 4 (SUMO4) protein associates with susceptibility to type 1 (and type 2) diabetes |
Q33417956 | Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence. |
Q37148579 | Posttranslational Protein Modifications in Type 1 Diabetes - Genetic Studies with PCMT1, the Repair Enzyme Protein Isoaspartate Methyltransferase (PIMT) Encoding Gene |
Q24538382 | Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 |
Q34247327 | SUMO conjugation contributes to immune deviation in nonobese diabetic mice by suppressing c-Maf transactivation of IL-4. |
Q57449327 | SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients |
Q34008085 | SUMO4 and its role in type 1 diabetes pathogenesis |
Q37034965 | Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population. |
Q43241836 | Small ubiquitin-like modifier-4 Met55Val polymorphism is associated with glycemic control of Type 2 diabetes mellitus in Taiwan |
Q35637247 | Study of the role of functional variants of SLC22A4, RUNX1 and SUMO4 in systemic lupus erythematosus |
Q38961119 | Sumoylation Modulates the Susceptibility to Type 1 Diabetes. |
Q30437398 | The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome. |
Search more.